CH666183A5 - Composizione farmaceutica ad azione protettiva cardiaca e metabolica sul metabolismo energetico muscolare. - Google Patents

Composizione farmaceutica ad azione protettiva cardiaca e metabolica sul metabolismo energetico muscolare. Download PDF

Info

Publication number
CH666183A5
CH666183A5 CH3362/85A CH336285A CH666183A5 CH 666183 A5 CH666183 A5 CH 666183A5 CH 3362/85 A CH3362/85 A CH 3362/85A CH 336285 A CH336285 A CH 336285A CH 666183 A5 CH666183 A5 CH 666183A5
Authority
CH
Switzerland
Prior art keywords
pharmaceutical composition
coenzyme
creatine phosphate
muscle
cardiac
Prior art date
Application number
CH3362/85A
Other languages
English (en)
Italian (it)
Inventor
Pierre-Noel Brasey
Original Assignee
Seuref Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Seuref Ag filed Critical Seuref Ag
Priority to CH3362/85A priority Critical patent/CH666183A5/it
Priority to DE19863625433 priority patent/DE3625433A1/de
Priority to GB8618589A priority patent/GB2178661B/en
Priority to NL8601979A priority patent/NL8601979A/nl
Priority to IT8621394A priority patent/IT1213319B/it
Priority to BE2/61025A priority patent/BE905210A/nl
Priority to JP61184973A priority patent/JPS6253924A/ja
Priority to FR868611375A priority patent/FR2586352B1/fr
Publication of CH666183A5 publication Critical patent/CH666183A5/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CH3362/85A 1985-08-06 1985-08-06 Composizione farmaceutica ad azione protettiva cardiaca e metabolica sul metabolismo energetico muscolare. CH666183A5 (it)

Priority Applications (8)

Application Number Priority Date Filing Date Title
CH3362/85A CH666183A5 (it) 1985-08-06 1985-08-06 Composizione farmaceutica ad azione protettiva cardiaca e metabolica sul metabolismo energetico muscolare.
DE19863625433 DE3625433A1 (de) 1985-08-06 1986-07-28 Pharmazeutische zusammensetzungen mit einer herz- und stoffwechsel-schuetzenden aktivitaet beim energetischen muskelstoffwechsel
GB8618589A GB2178661B (en) 1985-08-06 1986-07-30 Cardiac and muscular metabolic protecting compositions
NL8601979A NL8601979A (nl) 1985-08-06 1986-08-01 Farmaceutische preparaten met cardiale en metabolische beschermende werking op het energetische spiermetabolisme.
IT8621394A IT1213319B (it) 1985-08-06 1986-08-01 Composizione farmaceutica ad azione protettiva cardiaca e metabolica sul metabolismo energetico muscolare.
BE2/61025A BE905210A (nl) 1985-08-06 1986-08-04 Farmaceutische preparaten met cardiale en metabolische beschermende werking op het energetische spiermetabolisme.
JP61184973A JPS6253924A (ja) 1985-08-06 1986-08-05 心臓および筋代謝保護剤
FR868611375A FR2586352B1 (fr) 1985-08-06 1986-08-06 Compositions pharmaceutiques contenant une coenzyme du type ubiquinone, douees d'activite de protection cardiaque et metabolique sur le metabolisme energetique musculaire

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH3362/85A CH666183A5 (it) 1985-08-06 1985-08-06 Composizione farmaceutica ad azione protettiva cardiaca e metabolica sul metabolismo energetico muscolare.

Publications (1)

Publication Number Publication Date
CH666183A5 true CH666183A5 (it) 1988-07-15

Family

ID=4254335

Family Applications (1)

Application Number Title Priority Date Filing Date
CH3362/85A CH666183A5 (it) 1985-08-06 1985-08-06 Composizione farmaceutica ad azione protettiva cardiaca e metabolica sul metabolismo energetico muscolare.

Country Status (8)

Country Link
JP (1) JPS6253924A (fr)
BE (1) BE905210A (fr)
CH (1) CH666183A5 (fr)
DE (1) DE3625433A1 (fr)
FR (1) FR2586352B1 (fr)
GB (1) GB2178661B (fr)
IT (1) IT1213319B (fr)
NL (1) NL8601979A (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19537494C2 (de) * 1995-09-25 1997-10-02 Desitin Arzneimittel Gmbh Kreatin zum Schutz von neuralem Gewebe
CA2451163A1 (fr) * 2001-06-28 2003-01-09 Takeda Chemical Industries, Ltd. Medicaments destines a la prevention/au traitement de troubles fonctionnels des organes et du dysfonctionnement des organes
DE202023001978U1 (de) 2023-09-20 2023-09-29 Penta Phi Eg Formulierung umfassend Coenzym Q10 und Kreatin

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH655005A5 (it) * 1983-02-16 1986-03-27 Sigma Tau Ind Farmaceuti Composizione farmaceutica ad azione metabolica ed energetica utilizzabile in terapia cardiaca e vascolare.

Also Published As

Publication number Publication date
BE905210A (nl) 1986-12-01
GB2178661B (en) 1989-08-31
FR2586352B1 (fr) 1992-05-29
FR2586352A1 (fr) 1987-02-27
NL8601979A (nl) 1987-03-02
IT8621394A0 (it) 1986-08-01
GB8618589D0 (en) 1986-09-10
JPS6354690B2 (fr) 1988-10-28
DE3625433A1 (de) 1987-02-19
GB2178661A (en) 1987-02-18
IT1213319B (it) 1989-12-20
JPS6253924A (ja) 1987-03-09

Similar Documents

Publication Publication Date Title
US5545614A (en) Controlling nitrogen oxide concentrations to modulate skeletal muscle contraction
US20020094996A1 (en) Compositions and methods for lowering plasma lipoprotein(a) and risk factors of cardiovascular diseases
ITRM990467A1 (it) Composizione per la prevenzione degli affaticamenti muscolari e per migliorare il rendimento energetico muscolare.
AU675412B2 (en) Method of treating HIV infection
DE69125216D1 (de) Aminoalkanesulfonsäurederivate und pharmazeutische Zusammensetzungen davon zur Prävention oder Behandlung von Herzerkrankungen
DE69915143D1 (de) Pyridinium-derivate zur behandlung von altersbedingten und diabetischen vaskulären komplikationen, verfahren zu ihrer herstellung und ihre pharmazeutischen anwendungen
WO1996031217A9 (fr) Inhibition de la replication des retrovirus
CH670763A5 (fr)
Agarwal et al. Significance of plasma adenosine in the antiplatelet activity of forskolin: potentiation by dipyridamole and dilazep
ITRM20000323A1 (it) Integratore alimentare potenziante il metabolismo energetico muscolare, comprendente una alcanoil l-carnitina e ribosio.
JP3622985B2 (ja) マグネシウム吸収を高め、アテローム性動脈硬化症を防ぐ方法
CH666183A5 (it) Composizione farmaceutica ad azione protettiva cardiaca e metabolica sul metabolismo energetico muscolare.
EP0437929B1 (fr) Utilisation du diadénosin-5',5'''-p1,p4-tétraphosphate pour l'obtention d'un médicament pour le traitement des maladies cardiaques
BR9910628A (pt) Uso de um composto da série da benzofuroxana, composição farmacêutica, e, processos para a preparação de uma formulação parenteral e para o tratamento de um mamìfero, incluindo um ser humano, de doenças cardìacas da coronária
EP0530220B1 (fr) Composition pharmaceutique
EP0352746A2 (fr) Composition pour augmenter la disponibilité d'oxygène ou pour soulager l'hypoxie chez les mammifères
JP2002536325A (ja) 疾患を治療するためのｌ−アルギニン基盤の処方およびその使用方法
CA2959109A1 (fr) Procede d'amelioration de la production d'energie et du metabolisme dans des cellules
US4701462A (en) Method for prevention of hypertension
EP2586776A1 (fr) Isolateurs mitochondriaux cationiques mous
ITRM990436A1 (it) Composizione ad azione cardioattiva comprendente l-carnitina e suoi derivati ed estratti di crataegus.
BRPI0016329B8 (pt) bis-indolilmaleimidas substituídas para inibição de proliferação de células, seu processo de preparação e seu uso, bem como composição farmacêutica.
WO2022005848A1 (fr) Combinaisons de carnosine et de zinc pour le traitement et la prévention d'infections virales
EP1671630A2 (fr) Formulations basées sur l-arginine pour le traitment des maladies et méthodes utilisants les memes
YOSHITOSHI et al. Efficacy of Levocarnitine Chloride (LC-80) in Treatment of Ischemic Heart Diseases by the Serial Multistage Treadmill Exercise Testing A Multicenter Double-Blind Group-Comparison Study

Legal Events

Date Code Title Description
PL Patent ceased